BeiGene, a global biotechnology company focused on developing and commercializing innovative cancer medicines worldwide purchased a 42-acre site at the Princeton West Innovation Campus in Hopewell, NJ to build a new state-of-the-art manufacturing campus and clinical research & development center. Meyer, in conjunction with lead architect IPS, is part of the team designing approximately 400,000 square feet of dedicated commercial-stage biologic pharmaceutical manufacturing, clinical R&D space, and office space. Construction is expected to be completed in 2024.